Cascadian Therapeutics Target of Unusually Large Options Trading (NASDAQ:CASC)

Retrieved on: 2018-02-18 16:37:30

Tags for this article:

Politics

Cascadian Therapeutics Inc.

Cascadia

ONT-380

Click the tags to see associated articles and topics

Cascadian Therapeutics Target of Unusually Large Options Trading (NASDAQ:CASC). View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP bought a new stake in Cascadian Therapeutics during the fourth quarter worth approximately $181,000. Finally, Alps Advisors Inc. bought a new stake in Cascadian Therapeutics during the fourth quarter worth approximately $207,000. 80.59% of the stock is currently owned ...</div>

Article found on:

View Original Article